Moore TJ; Glenmullen J; Mattison DR (December 2014). «Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs». JAMA Internal Med.174 (12): 1930–1933. doi:10.1001/jamainternmed.2014.5262. PMID25329919.
Wolters ECh; van der Werf YD; van den Heuvel OA (September 2008). «Parkinson's disease-related disorders in the impulsive-compulsive spectrum». J. Neurol.255 Suppl 5: 48–56. doi:10.1007/s00415-008-5010-5. PMID18787882.
«A review of the receptor-binding and pharmacokinetic properties of dopamine agonists». Clinical Therapeutics28 (8): 1065–78. August 2006. doi:10.1016/j.clinthera.2006.08.004. PMID16982285.
«Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor». The Journal of Pharmacology and Experimental Therapeutics303 (2): 805–14. November 2002. doi:10.1124/jpet.102.039875. PMID12388667.
«Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes». The Journal of Pharmacology and Experimental Therapeutics303 (2): 791–804. November 2002. doi:10.1124/jpet.102.039867. PMID12388666.
Moore TJ; Glenmullen J; Mattison DR (December 2014). «Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs». JAMA Internal Med.174 (12): 1930–1933. doi:10.1001/jamainternmed.2014.5262. PMID25329919.
Wolters ECh; van der Werf YD; van den Heuvel OA (September 2008). «Parkinson's disease-related disorders in the impulsive-compulsive spectrum». J. Neurol.255 Suppl 5: 48–56. doi:10.1007/s00415-008-5010-5. PMID18787882.
«A review of the receptor-binding and pharmacokinetic properties of dopamine agonists». Clinical Therapeutics28 (8): 1065–78. August 2006. doi:10.1016/j.clinthera.2006.08.004. PMID16982285.
«Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor». The Journal of Pharmacology and Experimental Therapeutics303 (2): 805–14. November 2002. doi:10.1124/jpet.102.039875. PMID12388667.
«Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes». The Journal of Pharmacology and Experimental Therapeutics303 (2): 791–804. November 2002. doi:10.1124/jpet.102.039867. PMID12388666.
